NATESTO N
Live / Registered — Registered (as of 11 May 2021)
What this means for you
Registered since 11 May 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 11 May 2027, and its filing window is open now).
Record
- Serial number
- 90002018
- Registration number
- 6350052
- Mark type
- Design + words
- Filed
- 15 Jun 2020
- Published for opposition
- 27 Oct 2020
- Registered
- 11 May 2021
- Next maintenance filing
- §8 declaration of use, due by 11 May 2027 (grace period to 11 Nov 2027)
- Attorney of record
- Darrell G. Mottley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, testosterone supplementation
Owner
- Acerus Biopharma Inc., Mississauga, Ontario, CA
- Acerus Biopharma Inc., Mississauga, Ontario, CA
- Acerus Biopharma Inc., Mississauga, Ontario, CA
Prior registrations
Prosecution history
- 11 May 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Oct 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 28 Oct 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Oct 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 07 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Mar 2021 — USE AMENDMENT FILED
- 05 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 22 Dec 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Oct 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Oct 2020 — PUBLISHED FOR OPPOSITION